Journal Basic Info

  • Impact Factor: 2.709**
  • H-Index: 11 
  • ISSN: 2474-1663
  • DOI: 10.25107/2474-1663
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Kidney Cancer
  •  Breast Cancer
  •  Prostate Cancer
  •  Pancreatic Cancer
  •  Colorectal Cancer
  •  Stomach Cancer
  •  Immunotherapy
  •  Hematology

Abstract

Citation: Clin Oncol. 2021;6(1):1869.DOI: 10.25107/2474-1663.1869

DNA Damage Repair Proteins (PARP1, XRCC1 and POLβ) have Unfavorable Potential Prognostic Role in Primary Ovarian Cancer

Alabdullah ML, Miligy I, Alblihy A, Ali R, Toss M, Chan S, Madhusudan S and Rakha EA

Division of Cancer and Stem Cells, University of Nottingham Biodiscovery Institute, UK
Department of Pediatric Surgery, Leicester University Teaching Hospitals NHS Trust, UK
Department of Pathology, Menoufia University, Egypt
Department of Oncology, Nottingham University Hospitals, UK

*Correspondance to: Alabdullah ML 

 PDF  Full Text Research Article | Open Access

Abstract:

Background: DNA Damage Repair (DDR) proteins have crucial roles and can modify tumor behavior. XRCC1, PARP1 and polβ are important driving biomarkers that could enhance OC development and progression. They are key proteins in DDR. Although different studies have investigated their role in different cancerous organs, there remains a lack of knowledge on how the interaction between these proteins can influence the ovarian tumor cases. This study evaluates the biological and prognostic significance of the above proteins, in addition, to identify the one that has the dominating function in primary OC patients.
Methods: PARP1, XRCC1 and polβ expression was assessed immunohistochemically in a large primary OC cohort (n=525). Outcome analysis was evaluated using Progression Free (PFS) and Overall Survival (OS).
Results: High PARP1and XRCC1 expression was associated with features of high risk OC, including serous histology, advanced grade/stage, and higher residual tumor following surgery. Similarly, polβ overexpression was linked to serous histology and higher stage tumors. On the other hand, XRCC1 negative/low expression improved patients’ platinum sensitivity. Interestingly, overexpression of all the surrogate biomarkers was associated with poor outcome, not just in the whole cohort but also in platinum sensitive tumors. Importantly, the multivariate analysis revealed that XRCC1 is an independent factor for poor PFS and PARP1 for OS.
Conclusion: The DDR proteins (PARP1, XRCC1 and polβ) have crucial roles in OC progression and can potentially predict patients’ outcome. The data presented here reveal a novel network between the investigated proteins with vital clinical applications in OC. Therefore, this current study highlighted the critical role of this network, which could be utilized as a future therapeutic target in primary OC.

Keywords:

DNA Repair; XRCC1; PARP1; polβ; Ovarian cancer; Prognosis

Cite the Article:

Alabdullah ML, Miligy I, Alblihy A, Ali R, Toss M, Chan S, Madhusudan S, et al. DNA Damage Repair Proteins (PARP1, XRCC1 and POLβ) have Unfavorable Potential Prognostic Role in Primary Ovarian Cancer. Clin Oncol. 2021;6:1869..

Search Our Journal

Journal Indexed In

Articles in PubMed

LINGO-1 is a New Therapy Target and Biomarker for Ewing Sarcoma
 PubMed  PMC  PDF  Full Text
NMR Metabolomics in Ionizing Radiation
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

An Unusual Case of Papillary Thyroid Carcinoma with Solitary Cerebral Metastases Mimicking Cavernous Hemangioma
 Abstract  PDF  Full Text
Serum Vitamin D Levels in Diabetes Mellitus Patients with Pulmonary Tuberculosis
 Abstract  PDF  Full Text
View More...